Clinical Predictors of Extracorporal Shockwave Therapy Efficacy in Patients Presenting With Later… (NCT04058509) | Clinical Trial Compass
UnknownNot Applicable
Clinical Predictors of Extracorporal Shockwave Therapy Efficacy in Patients Presenting With Lateral Hip Pain
Denmark60 participantsStarted 2018-11-28
Plain-language summary
This pragmatic clinical trial is considering the variable response to treatment outcome of individuals with Greater Trochanteric Pain Syndrome (GTPS). The aim of this study is to identify predictors of focused extracorporeal shockwave therapy (fESWT) efficacy in individuals with GTPS. Specifically, the ability of clinically applicable measurements including: Patient demographics, co-morbidity, oestrogen levels, pain characteristics, hip abductor strength, time to pain during single-leg stance test, low back pain, and immediate pain reduction to local anaesthetic injection at the trochanter major insertion of Gluteus medius (GMed) during walking.
Who can participate
Age range
35 Years – 70 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Lateral hip pain, worst over the greater trochanter, present for a minimum of 3 months
* Age 35-70 years
* Female
* Pain at an average intensity of ≥3 out of 10 on most days of the last week.
* Tenderness on palpation of the greater trochanter
* Pain on one of the following:
Reproduction of pain on 30 sec single leg stand OR Positive Faber test
Exclusion Criteria:
* Any known advanced hip joint pathology where groin pain is the primary complaint and/or reproduction of groin pain with Faber or FADDIR.
* Where range of pure hip joint flexion is \<90°
* Radiating pain distal to the Gluteus Max + positive Straight Leg Raise (SLR-test \< 30°)
* Known advanced knee pathology or restricted range of knee motion (must have minimum 90° flexion and full extension)
* Any systemic diseases affecting the muscular or nervous system, and uncontrolled diabetes
* Malignant tumour OR Systemic inflammatory disease
* Any factors that would preclude the participant from having an MRI (e.g. pacemaker, metal implants, pregnancy, claustrophobia)
* If the participant is involved in a legal/workcover or other injury claim
* Fear of needles (trypanophobia)
* If the participant is unable to write, read or comprehend Danish
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.